Arkolith/Insider Trading/SRPT/Form 4

Arif Bilal

Chief Tech Ops OfficerSarepta Therapeutics, Inc. (SRPT) · full profile →Form 4 · filed Mar 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Grant(A)8K——33K
Mar 10, 2025Tax withholding(F)523$100.13$52K24K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2025Grant(A)17K—$017K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-037524) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML